Intensive versus conventional glycaemic control for treating diabetic foot ulcers

Area of Science:

• Diabetes Mellitus Research
• Wound Healing Studies
• Clinical Trial Methodology

Background:

• Diabetic foot ulcers precede 85% of non-traumatic amputations in diabetes patients.
• Diabetic peripheral neuropathy, peripheral arterial disease, and structural changes contribute to diabetic foot ulcers.
• Chronic hyperglycemia and altered metabolic states in diabetes are linked to these contributing factors.

Purpose of the Study:

• To evaluate the impact of intensive glycemic control versus conventional control on diabetic foot ulcer outcomes.
• To assess the efficacy of different glycemic management strategies in healing foot ulcers in patients with type 1 and type 2 diabetes.

Main Methods:

• Comprehensive search of multiple databases (Cochrane, MEDLINE, EMBASE, etc.) and trial registries for relevant randomized controlled trials (RCTs).
• Inclusion criteria focused on RCTs investigating intensive glycemic control interventions (e.g., insulin, oral agents, lifestyle changes) for active diabetic foot ulcers.
• Trials were required to measure glycemic control markers (HbA1c, glucose levels) and document effects on ulcer outcomes.

Main Results:

• Only one completed RCT met the inclusion criteria, but it lacked reported results.
• Two ongoing trials were identified, but their completion dates are unknown.
• No data was available to perform planned subgroup or sensitivity analyses.

Conclusions:

• The review could not conclude on the effectiveness of intensive glycemic control for diabetic foot ulcers due to a lack of completed trials with results.
• While intensive glycemic control may reduce amputation risk in type 2 diabetes generally, its specific benefit for foot ulcers remains undetermined.
• Further investigation is required to understand the role of intensive glycemic control within comprehensive, multidisciplinary care for diabetic foot ulcers.